Good MorningU.S. stocks turned sharply lower after the Federal Reserve raised interest rates by 25 basis points, its first hike in three years, while signaling that another increase could come this year. The Dow fell more than 1% in late trading, and the 10-year Treasury yield moved back above 5% as investors weighed Chair Kevin Warsh’s hawkish inflation stance and a divided outlook among Fed officials.
Technology shares were mixed. Intel climbed on reports it is in advanced talks with SK Hynix on a U.S. memory-chip manufacturing partnership tied to Intel’s Ohio facility, while fiber-optic names including Lumentum gained after Ciena’s long-term targets. GE Vernova also rose following bullish executive comments, but Salesforce slipped amid a widespread service outage and Boeing fell after its CEO said stabilizing 737 MAX production is taking longer than expected.
Energy remained a major market focus as crude prices surged toward $100 per barrel and a Saudi pipeline outage raised concerns about a temporary supply deficit. Exxon Mobil drew attention for its cash flow and buybacks, though options traders reportedly positioned for a potential pullback in energy stocks. Crypto assets weakened after the Senate failed to advance the CLARITY Act, with Bitcoin falling below $76,000. Featured: A Few Quiet Tickers Are Moving. (Stock News Trends Today) (Ad) 
|
Consumer Discretionary | |
Luxury brands must find a delicate balance between continuing to cultivate an air of exclusivity, maintaining perceived quality even in spite of higher materials costs and inflation, and balancing price increases against customer tolerance. While retail more broadly has faced numerous challenges as... Read the Full Story |
|
From Our Partners | | Small-cap moves rarely announce themselves. Street Ideas surfaces quiet setups with real momentum before they appear on mainstream radars.
With tomorrow's open approaching, three names are already showing early activity worth a closer look. Get the alerts that keep you ahead of the crowd. | | Join Street Ideas - Get Your Free Report Sent To Your Email |
|
Finance | |
When U.K.-based Prudential plc (NYSE: PUK) spun off its U.S. annuity business as Jackson Financial (NYSE: JXN) in September 2021, investors might have thought it was a complicated, hand-me-down life insurer. For its first two years, the stock barely moved.
Three years later, that has all changed. ... Read the Full Story |
|
Consumer Staples | |
Believe it or not, the holiday shopping season is here, so it's time to consider the best plays. As it stands, seasonal sales growth is expected to accelerate year over year to 4.55% to 4.8%, topping $1.7 trillion for the first time, underpinned as always by e-commerce. Digital sales are expected t... Read the Full Story |
|
From Our Partners | | CrowdStrike, Palantir, Nvidia none of them pay a real dividend. But one fund holding the biggest AI names distributes income every single Thursday, with payouts reported as high as $1,051 a month.
Chief Income Strategist Tim Plaehn breaks down the fund's real Thursday distribution history, how the income is generated, and how to buy it in any brokerage account. | | Watch the free presentation before this Thursday's payout |
|
Technology | |
AI leaders shocked the world by calling for a slowdown in AI’s advancement and for regulation. The news triggered a sector-wide drawdown, raising the risk of a deeper correction, but short sellers shouldn’t get their hopes up.
As scary as it may seem to AI investors, the slowdown in AI’s advancemen... Read the Full Story |
|
Technology | |
It’s impossible to take all the risk out of investing. But that doesn’t mean investors can’t make a good attempt. Stock prices are moving sharply on single headlines, and the winners and losers have shifted from month to month and week to week.
That’s an attractive environment for traders. However,... Read the Full Story |
|
From Our Partners | | Gold just broke another record - a classic flight-to-safety signal that the smartest money on Wall Street is already acting on. With the NASDAQ pricing in optimism over fundamentals and global tensions continuing to rise, a market correction could arrive without warning.
Our research team just released a free crash-protection guide identifying which stocks and sectors can hold strong even when the broader market crumbles. | | Download your free crash protection guide today |
|
Consumer Discretionary | |
Investors know Movado Group (NYSE: MOV) as a watch company. Analysts know it as a Strong Buy.
The company has spent the past year transforming from a tariff-battered lesson into a compelling turnaround story. It is riding two consecutive quarters of earnings beats, a debt-free balance sheet, a fre... Read the Full Story |
|
Technology | |
There’s a certain irony in a stock that has just rallied hard still being written off, yet that's exactly where chipmaker Qualcomm Inc. (NASDAQ: QCOM) finds itself right now. After a brutal 44% slide through much of the summer, its shares staged an impressive comeback, climbing around 30% since the... Read the Full Story |
|
Technology | |
Signals from chart price action to analysts' sentiment point to another massive run for Micron (NASDAQ: MU) stock. While headwinds and hurdles such as market angst, profit-taking, and repositioning weigh on price action today, long-term trends suggest at least another 100% upside. The hurdle in Sep... Read the Full Story |
|
Technology | |
Having had one of its worst days in recent memory following July’s earnings report, it's been a while since Apple Inc. (NASDAQ: AAPL) gave its shareholders much to smile about. However, the past week has been a welcome exception.
Since the company took the wraps off its latest products last Wednes... Read the Full Story |
|
Technology | |
Enterprise software spending has become more selective. Corporate budgets are facing tighter scrutiny, and management teams across corporate America are reviewing seat licenses, trimming cloud spend, and delaying optional application upgrades.
Cybersecurity spending, however, continues to run on a... Read the Full Story |
|
Thursday's Early Bird Stock Of The Day Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in the interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ. | Should I Buy Johnson & Johnson Stock? JNJ Bull and Bear Case Explained
These insights were generated using artificial intelligence. They are based on proprietary MarketBeat data, news articles, and custom LLM A.I. algorithms. This analysis of Johnson & Johnson was last updated on Thursday, October 29, 2026 at 6:24 PM.
Johnson & Johnson Bull Case -
Johnson & Johnson recently reported third-quarter adjusted earnings per share of $2.59, which exceeded the consensus estimate of $2.53, while revenue of $25.40 billion rose 5.9% year over year, demonstrating strong fundamental performance that supports the current stock price of $275.17.
-
The company presented a record 26 abstracts at the 2026 Transcatheter Cardiovascular Therapeutics conference, adding to more than two decades of data on the safety, efficacy, and cost-effectiveness of its Impella heart pumps, which reinforces the competitive positioning of its MedTech portfolio.
-
Johnson & Johnson is seeing rapid uptake of its oral plaque psoriasis therapy Icotyde in U.S. dermatology practices, with independent physician research indicating that prescriptions are building momentum and gaining share within the oral advanced therapy segment, potentially delaying the initiation of higher-cost biologic drugs.
-
Broader strength among large pharmaceutical companies is helping sector sentiment, with peers like Merck and Eli Lilly posting strong results, which places Johnson & Johnson among several major healthcare names attracting significant investor interest and capital flows.
-
The company maintains a stable dividend profile, having recently announced a quarterly dividend of $1.34 per share to be paid on December 8th, representing an annualized yield of approximately 1.9% that provides income stability for investors.
Johnson & Johnson Bear Case -
Pomerantz LLP is currently investigating claims on behalf of Johnson & Johnson investors, and while this does not establish wrongdoing, the renewed litigation attention may increase headline risk and investor uncertainty regarding the company's legal exposure.
-
Johnson & Johnson trades at a premium valuation with a P/E ratio of 41.69, and analysts are questioning whether the recent gains adequately reflect future cash-flow growth, noting that potential earnings pressure in 2027 could limit further upside.
-
Insiders have sold 64,515 shares of company stock worth approximately $17.27 million over the last 90 days, including recent sales by EVPs Jennifer Taubert and Elizabeth Forminard, which may signal a lack of confidence from company leadership at current price levels.
-
The company's dividend payout ratio stands at 81.21%, which is relatively high and may limit the flexibility of management to reinvest in growth initiatives or absorb potential earnings shocks in the future.
-
Short interest data shows that while the percentage of float shorted is low at approximately 0.70%, the absolute number of shares shorted remains significant at over 16.7 million, indicating that a portion of the market is still betting against the stock's performance.
| | View Today's Stock Pick |
|
